132 related articles for article (PubMed ID: 36103016)
1. MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.
Stojanović S; Dobrijević Z; Šelemetjev S; Đorić I; Janković Miljuš J; Živaljević V; Išić Denčić T
Endocrine; 2023 Jan; 79(1):98-112. PubMed ID: 36103016
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.
Dai L; Zhang W; Wu X; Zhou S
J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
[TBL] [Abstract][Full Text] [Related]
3. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
5. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
6. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
[TBL] [Abstract][Full Text] [Related]
8. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
11. BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients.
Stojanović S; Šelemetjev S; Đorić I; Janković Miljuš J; Tatić S; Živaljević V; Išić Denčić T
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137560
[TBL] [Abstract][Full Text] [Related]
12. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
13. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
14. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
15. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
16. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
[TBL] [Abstract][Full Text] [Related]
17. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
[TBL] [Abstract][Full Text] [Related]
19. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
